This document is a conclusive presentation that encompasses the perspective of antipsychotic reduction initiatives in the medical field.

Slides are as followed:

  • Faculty Disclosure
  • Learning Objectives
  • National Priority
  • FDA approved diagnoses
  • Common Off-label uses
  • Effectiveness in Dementia
  • Etc.

A Perspective on CMS’S Antipsychotic Reduction Initiative




We are working hard top provide valuable information for individuals and families. We make updates regularly so check back often. Join our Mailing list for UPDATE NOTICES and more information.


Frontline workers and Care Givers  ..WE APPRECIATE YOU! We are dedicated to helping you provide the highest Quality of Care and working hard to help Advance Quality Care in America.

Facility Owners

If you are a facility owner, we understand your unique position especially during these crazy times that is why we are teaming with the top professionals in research, legal and government to help you rise to the occasion.

Medicare Insurance